Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.14% to 9714.96, DAX (0.76%) to 23949.11, CAC40 (0.52%) to 8067.53, STOXX 600 (0.30%) to 570.58

Nov 04 ,2025

  • Synopsis:

    • European equity markets mostly ended the day lower, though above the worst levels of the session

    • Having initial opening lower, pan-European indices extended losses reaching the worst levels of the day around mid morning, before shares pared falls, helped by Wall St. doing the same after it opened

    • Limited drivers in Europe as market participants assessed the latest slew of earnings/updates, central bank speakers comments and UK fiscal policy, where pound and Gilts digested Chancellor's comments in early morning press conf regards upcoming budget

    • Shares were range-bound into the close, with Ireland +1.0% and Switzerland +0.4%, Belgium +0.2% along with FTSE100 bucking the lower trend and lead outperformers. Finland (1.2%) and Austria (1.1%) led underperformers

    • Netherlands election produced a fragmented outcome, with the government formation process, Rob Jetten's D66 party is expected to take the lead in a first round of talks to form a coalition government, seen taking some considerable time before an agreement is reached. French politics remains in focus as government looks to garner agreement on Budget 2026, with National Assembly debates continuing, the health budget at the centre of today's discussions. UK Chancellor gave a 'surprise' pre-budget, scene setter speech, and gave her clearest indication yet that taxes will increase for much of the nation, as Reeves looked to address speculation over autumn budget due on 26-Nov

    • Central bank speakers included Cyprus central bank's Patsalides at The Economist's 21st Annual Cyprus Summit and Bank of Spain's Escrivá spoke at conf. organised by Santander, with BOE's Breeden in fireside chat. Bank of Finland's Rehn says no major changes to outlook since ECB's Sep meeting. Bundesbank's Balz spoke at conf. on Digital Euro organised by the bank whilst Bundesbank's Nagel will speak at 18:00CET title 'Together we are stronger - how Europe is becoming fit for its new global role' at event organised by the bank.

    • EU's Dombrovskis, ESM's Gramegna participate in Bulgaria central bank's conf 'Bulgaria on the Doorstep of the Eurozone', where ECB's Lagarde spoke and gave press conf (event webcast (English) or Bulgarian).

    • In politics, Chancellor Merz continued his inaugural visits to the German states, this time to Mecklenburg-Western Pomerania. In UK, following Chancellor Reeves scene setter speech ahead of Budget 2025, business in the House of Commons kicked off with her facing MPs questions on Treasury and there's a debate on a motion(s) in the name of the Official Opposition (subjects supporting high streets as well as welfare spending). Committee topics include AI in financial services and the UK's fiscal framework.

    • EU's Jørgensen speech at the Strategic Energy Technology Plan (SET-Plan) Conf. NATO North Atlantic Council meeting, sees EU's Kubilius among the attendees.

    • Norway's Sandvik among the defence ministers from the ten JEF countries attending meeting (through Wed) to strengthen cooperation and security in Northern Europe, whilst minister of fisheries and the oceans Næss participates in Agenda Nord-Norge and minister of finance Stoltenberg participates in debate at the Storting about the Government Pension Fund Global's investments in Israeli companies. PM Støre spoke at Yara's autumn seminar and minister of energy Aasland participated in the National Tariff Conf for the Energy Sector, organized by the Electricity and IT Assn. Also, Handelsblatt Health (through Wed) and Handelsblatt Industry (through Wed), as well as Dagens industri's AI Customer Experience Summit and Small Business Evening

    • M&A news flow included Ørsted (ORSTED.DC) to divest 50% stake in Hornsea 3 to Apollo (APO). UKs' CMA clears Subsea7 (SUBC.NO), Saipem (SPM.IM) merger. TPG confirms acquisition of 70% equity interest in Kinetic Group via its Rise Climate Fund, with Foresight (FSG.LN) retaining a 30% stake.

    • Companies with shares responding positively to earnings/updates include Koninklijke Philips (PHIA.NA) reported better-than-expected Q3 numbers and reiterated FY25 outlook with EBITA margin now expected at the upper end of the range. OC Oerlikon Corp. (OERL.SW) post better-than-expected Q3 sales and orders. Geberit (GEBN.SW) after Q3 beat and raises FY net sales growth in local currencies guidance. BP (BP.LN) reports Q3 net income $2.21B vs consensus $2.02B. Amidst companies with declining share prices are, Telefonica (TEF.SM) Q3 earnings, CMD, Fresenius Medical Care (FME.GR) despite Q3 earnings beat with outlook 2025 confirmed. Evonik Industries (EVK.GR) reports Q3 adj. EPS €0.27 vs consensus €0.26. International Workplace Group (IWG.LN) published Q3 numbers and confirmed FY guidance. Associated British Foods (ABF.LN) shares reversed opening gains post FY results, the group also announced board review of Group structure that may lead to decision to undertake a separation of the Primark and Food businesses. There were monthly traffic statistics from Ryanair (RYA.ID) and Wizz Air (WIZZ.LN)

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Food & Beverage +0.91%, Health Care +0.81%, Utilities +0.63%, Real Estate+0.48%, Insurance +0.18%, Banks +0.10%, Construct & Mtls (0.20%), Media (0.20%)

      • Underperformers:

        • Basic Resources (2.01%), Telecom (1.68%), Retail (1.52%), Travel & Leisure (1.35%), Ind Goods & Svcs (1.25%), Technology (0.99%), Persnl & HHold Goods (0.58%), Chemicals (0.53%), Oil & Gas (0.45%), Autos & Parts (0.43%), Financial Svcs (0.43%)

    • Macro/Peripheral markets:

      • EU:

        • Environment ministers gather for meeting aimed at agreeing a general approach on a proposal to amend the European climate law to establish a binding intermediate climate target for 2040 - release

        • Adopted its annual Enlargement Package; shows progress towards EU membership for key enlargement partners - release

      • Finland:

        • Bank of Finland's Rehn says no major changes to outlook since ECB's Sep meeting - release

      • France:

        • Budget crisis deepens as tax amendments spiral out of control - FT, LeParisien

      • Greece:

        • Oct business expectations in industry index 104.9 vs prior 105.2 and year-ago 103.5 - IOBE

      • Ireland:

        • Government's long-awaited housing plan to be published within the next fortnight says Minister - RTE

      • Norway:

        • Country's total greenhouse gas emissions in 2024 decreased by (4.1%) y/y - government press release citing Statistics Office data

      • Sweden:

        • Elisabeth Thand Ringqvist introduced as the new leadership candidate by Anders Åkesson, chair of the Centre Party's nomination committee - The Local

      • UK:

        • Pursues US tariff relief on steel and whiskey - Bloomberg

        • PM Starmer signals income tax hike to avoid austerity cuts - FT

        • Chancellor Reeves vows fair tax rises in pre-budget address to spare NHS and tame debt mountain - London Times, Reuters

        • Chancellors scene setter speech ahead of Budget 2025 - release

        • Smaller budget hole at £14B - Resolution Foundation

    • Company news:

      • Notable Gainers

        • +17.2% DNR.IM (Industrie De Nora) -- Q3 net income €24.9M vs FactSet €20.9M [2 est, €19.9-22M]; reaffirms FY revenue, raises adj EBITDA margin guidance

        • +13.9% BICO.SS (BICO Group) -- Q3 EPS cont ops (SEK15.68) and unclear if comparable to FactSet (SEK1.02) [3 est, (SEK1.10)-(0.90)]; results include impairments

        • +13.2% ELG.GR (Elmos Semiconductor) -- Q3 EPS €1.37 vs FactSet €1.34 [1 est]; guides FY25

        • +7.7% ACAD.SS (AcadeMedia) -- buy from hold at ABG Sundal Collier

        • +4.8% COLO.B.DC (Coloplast) -- Q4 adj EBIT DKK1.95B vs consensus DKK1.90B; guides FY26

        • +4.5% B8FK.GR (Biofrontera) -- signs agreement with Propharma d.o.o. for the distribution of Ameluz in Croatia

        • +4.3% BAKKA.NO (Bakkafrost) -- Q3 operational EBIT DKK22M vs FactSet DKK82.1M [12 est, DKK22-105.3M]

        • +4.1% IPCO.SS (International Petroleum Corp) -- Q3 net income $3.8M vs FactSet $6.6M [7 est, ($1)-17M]

        • +4.1% DOTD.LN (dotDigital Group) -- FY adj EPS 4.8p vs FactSet 4.7p [6 est, 4.5-4.9p]

        • +4.1% SNWS.LN (Smiths News) -- FY EPS 11.1p vs FactSet 10.2p [2 est, 10.4-10.8p]

        • +4.0% GEBN.SW (Geberit) -- Q3 net income CHF155.8M vs StreetAccount CHF154.2M; now expects FY net sales growth in local currencies of around +4.5% vs prior guidance +4%

        • +3.8% A5G.ID (AIB Group) -- Q3 NIM €2.80B, (10%) as expected; FY25 NII expected to be > €3.7B vs prior > €3.6B

        • +3.5% PHIA.NA (Koninklijke Philips) -- Q3 EPS €0.36 ex-items vs consensus €0.32; reiterates FY25 outlook with EBITA margin now expected at the upper end of the range

        • +3.3% LTMC.IM (Lottomatica Group) -- 9M adj net income €257.4M ex-items, +60% vs year-ago €161M

        • +3.2% ENEA.SS (Enea) -- updates strategy and announces new financial guidance

        • +3.2% KIN.BB (Kinepolis Group) -- to buy Emagine Entertainment for $105M plus up to $15M growth-based earn-out

        • +3.0% WHA.NA (Wereldhave) -- 9M DRPS €1.36 vs year-ago €1.30

        • +3.0% BSLN.SW (Basilea Pharmaceutica) -- to receive $30M milestone payment triggered by strong Cresemba sales performance in Europe

        • +2.2% VIVE.SS (Vivesto) -- positive results were obtained from preclinical studies in an animal model of Acute Myeloid Leukemia

        • +2.1% VLA.FP (Valneva) -- positive results for Phase 1 Trial of Second-Generation Zika vaccine candidate

        • +2.1% SANN.SW (Santhera Pharmaceuticals) -- announces five-year data of AGAMREE (vamorolone) in patients with DMD show improved safety profile with comparable effectiveness to standard of care corticosteroids

        • +1.8% AKSO.NO (Aker Solutions) -- buy from hold at Fearnley

        • +1.7% OKEA.NO (Okea) -- Q3 EBITDA $117M vs FactSet $133.4M [5 est, $98-185M]

        • +1.5% AKER.NO (Aker) -- Q3 NAVPS NOK909, +19% vs year-ago NOK767

          • On earnings/updates: bp (BP.LN), ASPO.FH (Aspo) and reversing initial falls FAE.SM (FAES Farma)

      • Notable Declinersx

        • -14.0% ZTF.LN (Zotefoams) -- sustained its positive trading momentum during the period; performance in line with the board's expectations

        • -12.7% TEF.SM (Telefonica)

          • Q3 adj. EBITDA €3.07B vs consensus €3.04B; reaffirms FY revenue, EBITDA, capex guidance and dividend commitment for 2025

          • announces its strategic guidelines up to 2028 (mid-term) and 2030 (long-term) - CMD

        • -9.4% FME.GR (Fresenius Medical Care) -- Q3 EPS €0.94 vs consensus €0.86; outlook 2025 confirmed

        • -8.2% DURC.B.SS (Duroc) -- Q1 EPS (SEK0.35) vs year-ago (SEK0.06)

        • -8.1% EDEN.FP (Edenred) -- new 2025-28 outlook with its Amplify 25-28 plan - CMD

        • -7.9% SVIK.SS (Studsvik) -- Q3 EPS SEK0.44 vs FactSet SEK1.10 [1 est]

        • -7.3% NOBI.SS (Nobia) -- Q3 EPS (SEK0.55) including items and unclear if comparable to FactSet SEK0.00 [1 est]

        • -7.0% MMK.AV (Mayr-Melnhof Karton) -- Q3 net income €2.2M vs year-ago €14.9M

        • -6.1% XFAB.FP (X-FAB Silicon Foundries) -- hold from buy at Deutsche Bank

        • -5.1% SSAB.A.SS (SSAB) -- reiterates its financial targets; targets increase in premium offering as percent of the Group's total shipments - CMD

        • -5.1% TUNE.LN (Focusrite) -- FY EPS 16.7p vs FactSet 16.9p [5 est, 15.6-17.9p]

        • -4.9% VOLCAR.B.SS (Volvo Car) -- Oct car sales (2%) y/y to 60,455 units

        • -4.9% ATS.AV (AT & S Austria Technologie & Systemtechnik) -- Q2 net income (€7.6M) vs FactSet (€13M) [1 est]; comments on FY25/26 and FY26/27 outlook

        • -4.4% MULTI.NO (Multiconsult) -- Q3 EPS NOK1.41 vs FactSet NOK1.63 [4 est, NOK1.00-2.14]

        • -4.2% WIZZ.LN (Wizz Air Holdings) -- Oct traffic +13.1% y/y

        • -4.0% CLOUD.NO (Cloudberry Clean Energy) -- Q3 proportionate EBITDA NOK36M vs FactSet NOK42.3M [3 est, NOK22-57.8M]

        • -4.0% IWG.LN (International Workplace Group) -- Q3 system-wide revenue $1.13B, +4% y/y; confirms FY25 guidance

        • -3.7% NOEJ.GR (Norma Group) -- Q3 adj. EPS from cont. ops €0.05 vs FactSet (€1.03) [2 est, (€2.12)-0.06]

        • -3.4% PBB.GR (Deutsche Pfandbriefbank) -- reduce from hold at Kepler Cheuvreux

        • -3.4% SHA0.GR (Schaeffler) -- Q3 EBIT €264M ex-items vs FactSet €248.8M [5 est, €241-261M]

        • -3.3% DOM.LN (Domino's Pizza Group) -- Q3 System sales £382.7M vs year-ago £374.8M; confirms FY guidance; shares reversed initial gains

        • -2.8% SFQ.GR (SAF-HOLLAND4) -- prelim. 9M EBIT €121.1M vs year-ago €146.1M

        • -2.3% BOSS.GR (Hugo Boss) -- Q3 EPS €0.85 vs consensus €0.82; expects FY25 Group sales and EBIT at lower end of guidance ranges

        • -2.2% NEM.GR (Nemetschek) -- Q3 EPS €0.48 vs FactSet €0.46 [7 est, €0.41-0.53]

        • -1.5% RMS.FP (Hermes) -- equal weight from overweight at Barclays

          • On earnings/updates: BIM.FP (bioMerieux), HPOL.B.SS (HEXPOL), RYA.ID (Ryanair Holdings), BCHN.SW (Burckhardt Compression Holding), EVK.GR (Evonik Industries), GF.SW (Georg Fischer), INDT.SS (Indutrade), AFRY.SS (AFRY) and reversing initial gains ABF.LN (Associated British Foods), NDX1.GR (Nordex)

    • EU companies reporting tomorrow:

      • Earnings:

        • Austria: Verbund (VER.AV), Auto1 Group (AG1.AV)

        • Benelux: Koninklijke Ahold Delhaize (AD.NA), Royal Vopak (VPK.NA), Galapagos (GLPG.NA), AMG Critical Materials (AMG.NA), bpost (BPOST.BB)

        • Denmark: Novo Nordisk (NOVO.B.DC), Ørsted (ORSTED.DC), Vestas Wind Systems (VWS.DC), Pandora (PNDORA.DC), Ambu (AMBU.B.DC), Lån & Spar Bank (LASP.DC), cBrain (CBRAIN.DC), GrønlandsBANKEN (GRLA.DC)

        • Finland: Sampo (SAMPO.FH), HKFoods (HKFOODS.FH), Teleste (TLT1V.FH)

        • France: Bouygues (EN.FP), Jacquet Metals (JCQ.FP)

        • Germany: Siemens Healthineers (SHL.GR), Bayerische Motoren Werke (BMW.GR), Fresenius (FRE.GR), Vonovia (VNA.GR), Freenet (FNTN.GR), Kontron (KTN.GR), Evotec (EVT.GR), ZEAL Network (TIMA.GR), Washtec (WSU.GR), Kloeckner & Co. (KCO.GR), Koenig & Bauer (SKB.GR), Viemed Healthcare (VIJ.GR), Masterflex (MZX.GR), flatexDEGIRO (FTK.GR)

        • Italy: Telecom Italia (TIT.IM), Leonardo (LDO.IM), Snam (SRG.IM), Banca Generali (BGN.IM), Nexi (NEXI.IM), Diasorin (DIA.IM), Anima Holding (ANIM.IM), Ariston Holding (ARIS.IM)

        • Norway: Mowi (MOWI.NO), Wallenius Wilhelmsen (WAWI.NO), Wilh. Wilhelmsen Holding (WWI.NO), Kongsberg Automotive (KOA.NO), DOF Group (DOFG.NO), Norconsult (NORCO.NO), LINK Mobility Group Holding (LINK.NO), Odfjell (ODF.NO), Zaptec (ZAP.NO), Arctic Fish Holding (AFISH.NO), Saga Pure (SAGA.NO), Next Biometrics Group (NEXT.NO)

        • Portugal: EDP-Energias de Portugal (EDP.PL), EDP Renovaveis (EDPR.PL)

        • Spain: Laboratorio Reig Jofre (RJF.SM)

        • Sweden: Sinch (SINCH.SS), Medicover (MCOV.B.SS), Storskogen Group (STOR.B.SS), Ambea (AMBEA.SS), Cloetta (CLA.B.SS), Haypp Group (HAYPP.SS), Kambi Group (KAMBI.SS), Karnell Group (KARNEL.B.SS), Bredband2 i Skandinavien (BRE2.SS), Vicore Pharma Holding (VICO.SS), Devyser Diagnostics (DVYSR.SS), Oncopeptides (ONCO.SS), Orrön Energy (ORRON.SS), SinterCast (SINT.SS), G5 Entertainment (G5EN.SS), Wastbygg Gruppen (WBGR.B.SS), Ascelia Pharma (ACE.SS), Eniro Group (ENRO.SS)

        • Switzerland: Barry Callebaut (BARN.SW)

        • UK: CRH (CRH.LN), Marks & Spencer Group (MKS.LN), Burford Capital (BUR.LN), Trainline (TRN.LN), Braemar (BMS.LN)

      • Trading Statement:

        • Benelux: Coca-Cola Europacific Partners (CCEP.NA), Wolters Kluwer (WKL.NA), Jensen-Group (JEN.BB)

        • France: Teleperformance (TEP.FP), Neurones (NRO.FP), Equasens Group (EQS.FP), Figeac Aero (FGA.FP), Compagnie Chargeurs Invest (CRI.FP), Solutions 30 (S30.FP), Bilendi (ALBLD.FP)

        • Nordics: ISS (ISS.DC)

        • Southern Europe: Buzzi (BZU.IM)

        • UK: Barratt Redrow (BTRW.LN), TP ICAP Group (TCAP.LN), Lancashire Holdings (LRE.LN), Conduit Holdings (CRE.LN), Vanquis Banking Group (VANQ.LN)

        • Other: Glanbia (GL9.ID)

      • Sales: Avanza Bank Holding (AZA.SS), Nordnet (SAVE.SS)

      • CMD/events: Royal KPN (KPN.NA) Strategy Update Call, Nordea Bank (NDA.SE.SS), Melexis (MELE.BB), Anora Group (ANORA.FH), Alleima (ALLEI.SS), Troax Group (TROAX.SS)

  • Data:

    • Economics:

      • Spain Oct unemployment change +22.1K vs consensus +5.2K, prior (4.8K)

    • Markets:

      • WTI Crude (Dec 25): ($0.36) or (0.59%) to $60.69

      • €-$ (0.0026) or (0.23%) to 1.1493

      • £-$ (0.0091) or (0.69%) to 1.3048

      • €-£ +0.0042 to 0.8810

      • S&P 500 (0.71%)

      • Performance year-to-date:

        • FTSE 100: +18.87%

        • DAX: +20.29%

        • CAC: +9.31%

        • MIB: +26.42%

        • Stoxx 600: +12.40%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE